phesgo soln for inj 1,200 mg-600 mg

Phesgo soln for inj 1,200 mg/600 mg (1200 mg)

Manufacturer: Roche

Distributor: DKSH

Marketer: Roche

Contents: pertuzumab, trastuzumab

MIMS Class: Targeted Cancer Therapy

Form: Vial

Register or sign in to continue

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in